MonoRab™ Anti-Pembrolizumab Antibody(129G11B9), mAb, Rabbit
该产品已下架。
Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. GenScript MonoRab™ Anti-Pembrolizumab Antibody (129G11B9), mAb, Rabbit is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a rabbit immunized with Pembrolizumab.
A01852 | |
|
|
|
|
联系我们 |